Pune, Maharashtra, September 27, 2024 – In a concerted effort to combat the growing challenge of tuberculosis (TB), the HEAL Foundation, in collaboration with Mylan Pharmaceuticals Private Limited (a Viatris company), has launched the India Fights TB campaign in Maharashtra targeting Pune Rural and Dharashiv district.
The multi-channel campaign activities are designed to support the local population using culturally aligned methods to engage and educate. Nukkad Nataks, a traditional form of street theatre, will dramatize TB-related issues; radio activations will broadcast informative content to reach a wider audience. Additionally, subject matter expert interviews will feature prominent personalities discussing TB prevention and treatment, further amplifying the message.
The HEAL Foundation, spearheading the campaign, is working to raise awareness and educate the public about TB. Dr. Swadeep Srivastava, Founder of the HEAL Foundation, expressed his enthusiasm for the project, saying, "Our mission is to ensure that every individual, regardless of their geographical location, has access to critical information about TB. Through engaging activities like Nukkad Nataks, impactful radio activations, and our knowledge portal www.indiafightstb.com, we aim to break down the barriers to knowledge and foster a more informed and proactive community."
In support of this initiative, Viatris is providing vital backing to ensure success. Dr. Dhara Shah, Head of Medical Affairs at Viatris India, highlighted the company's dedication to the cause, stating, "Viatris is proud to support the India Fights TB initiative as part of our commitment to improving global health. Our collaboration with the HEAL Foundation reflects our shared vision of eradicating TB through education, prevention, and effective treatment. We believe that by combining our resources and expertise, we can make a significant difference in the fight against tuberculosis."
The India Fights TB campaign is set to be a landmark effort in the push against tuberculosis, aiming to raise awareness and inspire action and change. The initiative is poised to make a meaningful impact in the fight against TB with key stakeholders' support and community involvement.
For more information about the India Fights TB campaign and its activities, please visit www.indiafightstb.com.
About Viatris
Viatris Inc. (NASDAQ: VTRS) is a global healthcare company uniquely positioned to bridge the traditional divide between generics and brands, combining the best of both to more holistically address healthcare needs globally. With a mission to empower people worldwide to live healthier at every stage of life, we provide access at scale, currently supplying high-quality medicines to approximately 1 billion patients around the world annually and touching all of life's moments, from birth to the end of life, acute conditions to chronic diseases. With our exceptionally extensive and diverse portfolio of medicines, a one-of-a-kind global supply chain designed to reach more people when and where they need them, and the scientific expertise to address some of the world's most enduring health challenges, access takes on deep meaning at Viatris. We are headquartered in the U.S., with global centers in Pittsburgh, Shanghai and Hyderabad, India. Learn more at viatris.com and investor.viatris.com, and connect with us on LinkedIn, Instagram, YouTube and X (formerly Twitter).
